Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors

Clinical trial NCT05538195 · COMPLETED

Trial details

NCT number: NCT05538195
Sponsor: Chongqing Precision Biotech Co., Ltd
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Gastric Cancer Colon Cancer Rectal Cancer Esophageal Cancer Pancreatic Cancer

Start date: 2022-06-07
Primary completion: 2023-12-30
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.